Additionally, studies conducted by Bernardi et al. [68] and Liao et al. [69] identified a high pre-treatment serum ALB–BIL grade as an independent predictor for worse OS and RFS in HCC patients undergoing liver transplantation. The gene discussed is ALB; the disease is hepatocellular carcinoma.